About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2014 (2014), Article ID 863595, 6 pages
http://dx.doi.org/10.1155/2014/863595
Research Article

Characteristics of Metachronous Gastric Tumors after Endoscopic Submucosal Dissection for Gastric Intraepithelial Neoplasms

1Department of Gastroenterology and Metabolism, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8551, Japan
2Department of Endoscopy, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8551, Japan
3Health Service Center, Hiroshima University, 1-7-1 Kagamiyama, Higashi-Hiroshima 739-8514, Japan
4Department of Pathology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8551, Japan

Received 2 December 2013; Revised 3 January 2014; Accepted 4 January 2014; Published 11 February 2014

Academic Editor: Sergio Morini

Copyright © 2014 Tomoyuki Boda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. P. Curado, B. Edwards, H. R. Shin, et al., Cancer Incidence in Five Continents, vol. 9, IARC Scientific Publication, Lyon, France, 2009.
  2. J. Parsonnet, G. D. Friedman, D. P. Vandersteen et al., “Helicobacter pylori infection and the risk of gastric carcinoma,” The New England Journal of Medicine, vol. 325, no. 16, pp. 1127–1131, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Nomura, G. N. Stemmermann, P.-H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser, “Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii,” The New England Journal of Medicine, vol. 325, no. 16, pp. 1132–1136, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Uemura, S. Okamoto, S. Yamamoto et al., “Helicobacter pylori infection and the development of gastric cancer,” The New England Journal of Medicine, vol. 345, no. 11, pp. 784–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Nakajima, I. Oda, T. Gotoda et al., “Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?” Gastric Cancer, vol. 9, no. 2, pp. 93–98, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Nasu, T. Doi, H. Endo, T. Nishina, S. Hirasaki, and I. Hyodo, “Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection,” Endoscopy, vol. 37, no. 10, pp. 990–993, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Fukase, M. Kato, S. Kikuchi et al., “Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial,” The Lancet, vol. 372, no. 9636, pp. 392–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. C. Wong, S. K. Lam, W. M. Wong et al., “Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial,” The Journal of the American Medical Association, vol. 291, no. 2, pp. 187–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Oka, S. Tanaka, I. Kaneko et al., “Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer,” Gastrointestinal Endoscopy, vol. 64, no. 6, pp. 877–883, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Gotoda, H. Yamamoto, and R. M. Soetikno, “Endoscopic submucosal dissection of early gastric cancer,” Journal of Gastroenterology, vol. 41, no. 10, pp. 929–942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Imagawa, H. Okada, Y. Kawahara et al., “Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as sucsess,” Endoscopy, vol. 38, no. 10, pp. 987–990, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Oda, D. Saito, M. Tada et al., “A multicenter retrospective study of endoscopic resection for early gastric cancer,” Gastric Cancer, vol. 9, no. 4, pp. 262–270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Nozaki, J. Nasu, Y. Kubo, M. Tanada, R. Nishimura, and A. Kurita, “Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery,” World Journal of Surgery, vol. 34, no. 7, pp. 1548–1554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Han, J. S. Jang, S. R. Choi et al., “A study of metachronous cancer after endoscopic resection of early gastric cancer,” Scandinavian Journal of Gastroenterology, vol. 46, no. 9, pp. 1099–1104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Kato, T. Nishida, K. Yamamoto, et al., “Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group,” Gut, vol. 62, no. 10, pp. 1425–1432, 2013. View at Publisher · View at Google Scholar
  16. T. Kitoh, H. Yanai, Y. Matsubara et al., “Endoscopic findings potentially predictive of gastric cancer in borderline lesions diagnosed by forceps biopsy,” Hepato-Gastroenterology, vol. 52, no. 62, pp. 404–408, 2005. View at Scopus
  17. Japanese Gastric Cancer Association, “Japanese gastric cancer treatment guidelines 2010 (ver. 3),” Gastric Cancer, vol. 14, no. 2, pp. 113–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Japanese Gastric Cancer Association, “Japanese classification of gastric carcinoma: 3rd english edition,” Gastric Cancer, vol. 14, no. 2, pp. 101–112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Kimura and T. Takemoto, “An endoscopic recognition of the atrophic border and its significance in chronic gastritis,” Endoscopy, vol. 1, no. 3, pp. 87–97, 1969. View at Publisher · View at Google Scholar
  20. T. Gotoda, A. Yanagisawa, M. Sasako et al., “Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers,” Gastric Cancer, vol. 3, no. 4, pp. 219–225, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Gotoda, M. Iwasaki, C. Kusano, S. Seewald, and I. Oda, “Endoscopie resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria,” British Journal of Surgery, vol. 97, no. 6, pp. 868–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Sanomura, S. Oka, S. Tanaka et al., “Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study,” Gastric Cancer, vol. 15, no. 1, pp. 97–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Sanomura, S. Oka, S. Tanaka et al., “Predicting the absence of lymph node metastasis of submucosal invasive gastric cancer: expansion of the criteria for curative endoscopic resection,” Scandinavian Journal of Gastroenterology, vol. 45, no. 12, pp. 1480–1487, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. Lim, H.-W. Lee, H. Im et al., “Predictable factors for lymph node metastasis in early gastric cancer-analysis of single institutional experience,” Journal of Gastrointestinal Surgery, vol. 15, no. 10, pp. 1783–1788, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Fujii, Y. Egashira, H. Akutagawa, et al., “Pathological factors related to lymph node metastasis of submucosally invasive gastric cancer: criteria for additional gastrectomy after endoscopic resection,” Gastric Cancer, vol. 16, no. 4, pp. 521–530, 2013. View at Publisher · View at Google Scholar
  26. T. Hirasawa, T. Gotoda, S. Miyata et al., “Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer,” Gastric Cancer, vol. 12, no. 3, pp. 148–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Hanaoka, S. Tanabe, T. Mikami, I. Okayasu, and K. Saigenji, “Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection,” Endoscopy, vol. 41, no. 5, pp. 427–432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Kunisaki, M. Takahashi, Y. Nagahori et al., “Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer,” Endoscopy, vol. 41, no. 6, pp. 498–503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-H. Tong, Z. Sun, Z.-N. Wang et al., “Early gastric cancer with signet-ring cell histologic type: risk factors of lymph node metastasis and indications of endoscopic surgery,” Surgery, vol. 149, no. 3, pp. 356–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Higashimaya, S. Oka, S. Tanaka, et al., “Outcome of endoscopic submucosal dissection for gastric neoplasm in relationship to endoscopic classification of submucosal fibrosis,” Gastric Cancer, vol. 16, no. 3, pp. 404–410, 2013. View at Publisher · View at Google Scholar
  31. M. Higashimaya, S. Oka, S. Tanaka, et al., “Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection,” Gastrointestinal Endoscopy, vol. 77, no. 2, pp. 298–302, 2013. View at Publisher · View at Google Scholar
  32. M. Kobayashi, R. Narisawa, Y. Sato, M. Takeuchi, and Y. Aoyagi, “Self-limiting risk of metachronous gastric cancers after endoscopic resection,” Digestive Endoscopy, vol. 22, no. 3, pp. 169–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Kato, M. Asaka, T. Nakamura et al., “Helicobacter pylori eradication prevents the development of gastric cancer,” Alimentary Pharmacology & Therapeutics Symposium Series, vol. 2, no. 1, pp. 203–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Nishino, M. Inoue, I. Tsuji et al., “Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population,” Japanese Journal of Clinical Oncology, vol. 36, no. 12, pp. 800–807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Tsugane, S. Sasazuki, M. Kobayashi, and S. Sasaki, “Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women,” British Journal of Cancer, vol. 90, no. 1, pp. 128–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Arima, K. Adachi, T. Katsube et al., “Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment,” Journal of Clinical Gastroenterology, vol. 29, no. 1, pp. 44–47, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Miyoshi, K. Haruma, T. Hiyama, et al., “Microsatellite instability is a genetic marker for the development of multiple gastric cancers,” International Journal of Cancer, vol. 95, no. 6, pp. 350–353, 2001.
  38. S. H. Kim, B. K. Ahn, Y. S. Nam, J. Y. Pyo, Y. H. Oh, and K. H. Lee, “Microsatellite instability is associated with the clinicopathologic features of gastric cancer in sporadic gastric cancer patients,” Journal of Gastric Cancer, vol. 10, no. 4, pp. 149–154, 2010. View at Publisher · View at Google Scholar
  39. P. Sipponen, J. Valle, K. Varis, M. Kekki, T. Ihamäki, and M. Siurala, “Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa: an analysis of 860 subjects,” Scandinavian Journal of Gastroenterology, vol. 25, no. 5, pp. 513–519, 1990. View at Scopus
  40. B. Germaná, F. di Mario, L. G. Cavallaro et al., “Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care,” Digestive and Liver Disease, vol. 37, no. 7, pp. 501–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Miki, M. Ichinose, and A. Shimizu, “Serum pepsinogens as a screening test of extensive chronic gastritis,” Gastroenterologia Japonica, vol. 22, no. 2, pp. 133–141, 1987. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Kiyohira, M. Yoshihara, M. Ito, K. Haruma, S. Tanaka, and K. Chayama, “Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels,” Journal of Gastroenterology, vol. 38, no. 4, pp. 332–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Uemura, T. Mukai, S. Okamoto et al., “Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer,” Cancer Epidemiology, Biomarkers & Prevention, vol. 6, no. 8, pp. 639–642, 1997. View at Scopus
  44. M. Asaka, M. Kato, S.-I. Takahashi et al., “Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition,” Helicobacter, vol. 15, no. 1, pp. 1–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Ito, S. Tanaka, S. Takata et al., “Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up,” Alimentary Pharmacology & Therapeutics, vol. 21, no. 5, pp. 559–566, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Takata, M. Ito, M. Yoshihara et al., “Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report,” Journal of Gastroenterology and Hepatology, vol. 22, no. 4, pp. 571–576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Matsuo, M. Ito, M. Tatsugami et al., “Gastric cancer development after Helicobacter pylori eradication therapy: a new form of gastric neoplasia,” Digestion, vol. 85, no. 1, pp. 61–67, 2012. View at Publisher · View at Google Scholar · View at Scopus